The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Inactivation of the Friedreich ataxia mouse gene leads to early embryonic lethality without iron accumulation
Abstract
Friedreich ataxia (FRDA), the most common autosomal recessive ataxia, is caused in almost all cases by homozygous intronic expansions resulting in the loss of frataxin, a mitochondrial protein conserved through evolution, and involved in mitochondrial iron homeostasis. Yeast knockout models, and histological and biochemical data from patient heart biopsies or autopsies indicate that the frataxin defect causes a specific iron-sulfur protein deficiency and mitochondrial iron accumulation leading to the pathological changes. Affected human tissues are rarely available to further examine this hypothesis. To study the mechanism of the disease, we generated a mouse model by deletion of exon 4 leading to inactivation of the Frda gene product. We show that homozygous deletions cause embryonic lethality a few days after implantation, demonstrating an important role for frataxin during early development. These results suggest that the milder phenotype in humans is due to residual frataxin expression associated with the expansion mutations. Surprisingly, in the frataxin knockout mouse, no iron accumulation was observed during embryonic resorption, suggesting that cell death could be due to a mechanism independent of iron accumulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies in the liver demonstrated that C/EBPα plays a role in the iron-mediated regulation of hepcidin mRNA (58).”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [58]
In the citing paper
“levels of C/EBPα transcription factor in murine liver are doubled in response to iron loading,”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [58]
In the citing paper
“mice deficient in C/EBPα exhibited lower levels of hepcidin mRNA,”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [58]
In the citing paper
“suggesting that C/EBPα modulates hepcidin transcription (58).”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [58]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular cloning: A laboratory manual
Deininger, P. L. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,684
Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging
Mori, S., Crain, B. J., Chacko, V. P., & van Zijl, P. C. M. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199902)45:2 · Cited by 3,513
Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion
Campuzano, V., Montermini, L., Moltò, M. D., Pianese, L., Cossée, M., Cavalcanti, F., Monros, E., Rodius, F., Duclos, F., Monticelli, A., et al. (1996) · Science · doi:10.1126/science.271.5254.1423 · Cited by 2,786
Lantos, P. L. (1985) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.48.5.496 · Cited by 1,156
Clinical and Genetic Abnormalities in Patients with Friedreich's Ataxia
Dürr, A., Cossee, M., Agid, Y., Campuzano, V., Mignard, C., Penet, C., Mandel, J.-L., Brice, A., & Koenig, M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610173351601 · Cited by 1,071
Harding, A. E. (1981) · Brain · doi:10.1093/brain/104.3.589 · Cited by 929
Frataxin is Reduced in Friedreich Ataxia Patients and is Associated with Mitochondrial Membranes
Campuzano, V., Montermini, L., Lutz, Y., Cova, L., Hindelang, C., Jiralerspong, S., Trottier, Y., Kish, S. J., Faucheux, B. A., Trouillas, P., et al. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.11.1771 · Cited by 739
The mitochondrial proteins Atm1p and Nfs1p are essential for biogenesis of cytosolic Fe/S proteins
Kispál, G., Csere, P., Prohl, C., & Lill, R. (1999) · The EMBO Journal · doi:10.1093/emboj/18.14.3981 · Cited by 699
Schrank, B., Götz, R., Gunnersen, J. M., Ure, J., Toyka, K. V., Smith, A. G., & Sendtner, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9920 · Cited by 661
Filla, A., Michele, G. D., Cavalcanti, F., Pianese, L., Monticelli, A., Campanella, G., & Cocozza, S. (1996) · PubMed Central · Cited by 487
Flagged first, then by citations
Research works printed but not linked: 1
- Dierich, A. and Dollé, P. (1997) In Klug, S. and Thiel, R. (eds), Methods in Developmental Toxicology and Biology. Blackwell Science, Oxford, UK, pp. 111-123.
Cited by
Sorted by citations
Items 101–200 of 376
Reduced expression of frataxin extends the lifespan of Caenorhabditis elegans
Ventura, N., Rea, S. L., Henderson, S. T., Condò, I., Johnson, T. E., & Testi, R. (2005) · Aging Cell · doi:10.1111/j.1474-9726.2005.00149.x · Cited by 81
Suppression of complex I gene expression induces optic neuropathy
Qi, X., Lewin, A. S., Hauswirth, W. W., & Guy, J. R. (2003) · Annals of Neurology · doi:10.1002/ana.10426 · Cited by 82
Pandolfo, M. (2003) · Seminars in Pediatric Neurology · doi:10.1016/s1071-9091(03)00025-1 · Cited by 81
Friedreich's Ataxia: From Disease Mechanisms to Therapeutic Interventions
Lodi, R., Tonon, C., Calabrese, V., & Schapira, A. H. V. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.438 · Cited by 79
Frataxin deficiency enhances apoptosis in cells differentiating into neuroectoderm
Santos, M. M. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.18.1935 · Cited by 79
Sahdeo, S., Scott, B. D., McMackin, M. Z., Jasoliya, M., Brown, B. M., Wulff, H., Perlman, S., Pook, M. A., & Cortopassi, G. A. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu408 · Cited by 81
Shoichet, S. A. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.7.815 · Cited by 78
Intermediary Metabolism and Energetics during Murine Early Embryogenesis
Johnson, M. T., Mahmood, S., & Patel, M. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r300002200 · Cited by 77
Targeting lipid peroxidation and mitochondrial imbalance in Friedreich's ataxia
Abeti, R., Uzun, E., Renganathan, I., Honda, T., Pook, M. A., & Giunti, P. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.05.015 · Cited by 77
Becker, E., Greer, J. M., Ponka, P., & Richardson, D. R. (2002) · Blood · doi:10.1182/blood.v99.10.3813 · Cited by 74
Friedreich's Ataxia, No Changes in Mitochondrial Labile Iron in Human Lymphoblasts and Fibroblasts
Sturm, B., Bistrich, U., Schranzhofer, M., Sarsero, J. P., Rauen, U., Scheiber-Mojdehkar, B., de Groot, H., Ioannou, P., & Petrat, F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408717200 · Cited by 73
Martelli, A., Напиерала, М., & Puccio, H. M. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.008706 · Cited by 80
Friedreich Ataxia: Hypoplasia of Spinal Cord and Dorsal Root Ganglia
Koeppen, A. H., Becker, A. B., Qian, J., & Feustel, P. J. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw111 · Cited by 73
Runko, A. P., Griswold, A. J., & Min, K. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.01.046 · Cited by 72
Drosophila Frataxin: An Iron Chaperone during Cellular Fe−S Cluster Bioassembly
Kondapalli, K. C., Kok, N. M., Dancis, A., & Stemmler, T. L. (2008) · Biochemistry · doi:10.1021/bi800366d · Cited by 70
Friedreich ataxia?update on pathogenesis and possible therapies
Voncken, M., Ioannou, P. A., & Delatycki, M. B. (2004) · Neurogenetics · doi:10.1007/s10048-003-0170-z · Cited by 70
Pandolfo, M. (2002) · Cited by 70
Donato, S. D., Gellera, C., & Mariotti, C. (2001) · Neurological Sciences · doi:10.1007/s100720100017 · Cited by 69
Lin, H., Magrané, J., Rattelle, A., Степанова, А., Galkin, A. S., Clark, E. M., Dong, Y., Halawani, S. M., & Lynch, D. R. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.030502 · Cited by 68
Oxidative Stress, a Crossroad Between Rare Diseases and Neurodegeneration
Espinós, C., Galindo, M. I., García-Gimeno, M. A., Ibáñez-Cabellos, J. S., Martínez‐Rubio, D., Millán, J. M., Rodrigo, R., Sanz, P., Seco-Cervera, M., Sevilla, T., et al. (2020) · Antioxidants · doi:10.3390/antiox9040313 · Cited by 69
Upregulation of expression from the FRDA genomic locus for the therapy of Friedreich ataxia
Sarsero, J. P., Li, L., Wardan, H., Sitte, K., Williamson, R., & Ioannou, P. A. (2002) · The Journal of Gene Medicine · doi:10.1002/jgm.320 · Cited by 67
Mitochondrial DNA release and sensing in innate immune responses
VanPortfliet, J. J., Chute, C., Lei, Y., Shutt, T. E., & West, A. P. (2024) · Human Molecular Genetics · doi:10.1093/hmg/ddae031 · Cited by 70
Lange, H., Mühlenhoff, U., Denzel, M. S., Kispál, G., & Lill, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403721200 · Cited by 66
Iron Metabolism and Mitochondrial Abnormalities in Friedreich Ataxia
Pandolfo, M. (2002) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2002.0591 · Cited by 65
Pastore, C., Franzese, M., Sica, F., Temussi, P., & Pastore, A. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.05946.x · Cited by 64
A novel GAA repeat expansion-based mouse model of Friedreich ataxia
Virmouni, S. A., Ezzatizadeh, V., Sandi, C., Sandi, M., Al‐Mahdawi, S., Chutake, Y. K., & Pook, M. A. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.018952 · Cited by 62
Linking Cancer Metabolic Dysfunction and Genetic Instability through the Lens of Iron Metabolism
Petronek, M. S., Spitz, D. R., Buettner, G. R., & Allen, B. G. (2019) · Cancers · doi:10.3390/cancers11081077 · Cited by 66
Distinct Iron Binding Property of Two Putative Iron Donors for the Iron-Sulfur Cluster Assembly
Ding, H., Yang, J., Coleman, L. C., & Yeung, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609665200 · Cited by 61
Drug Insight: antioxidant therapy in inherited ataxias
Pandolfo, M. (2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0704 · Cited by 60
Knockout of frataxin gene causes embryo lethality in Arabidopsis
Vazzola, V., Losa, A., Soave, C., & Murgia, I. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.01.030 · Cited by 60
Cerebral abnormalities in Friedreich ataxia: A review
Selvadurai, L. P., Harding, I. H., Corben, L. A., & Georgiou‐Karistianis, N. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.08.006 · Cited by 60
Calmels, N., Schmucker, S., Wattenhofer‐Donzé, M., Martelli, A., Vaucamps, N., Reutenauer, L., Messaddeq, N., Bouton, C., Koenig, M., & Puccio, H. M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006379 · Cited by 59
Friedreich Ataxia: Developmental Failure of the Dorsal Root Entry Zone
Koeppen, A. H., Becker, A. B., Qian, J., Gelman, B. B., & Mazurkiewicz, J. E. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlx087 · Cited by 59
Iron Dysregulation in Friedreich Ataxia
Wilson, R. B. (2006) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2006.08.005 · Cited by 59
Zarse, K., Schulz, T. J., Birringer, M., & Ristow, M. (2007) · The FASEB Journal · doi:10.1096/fj.06-6994com · Cited by 58
Frataxin participates to the hypoxia-induced response in tumors
Guccini, I., Serio, D., Condò, I., Rufini, A., Tomassini, B., Mangiola, A., Maira, G., Anile, C., Fina, D., Pallone, F., et al. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.5 · Cited by 57
Multicellular models of Friedreich ataxia
Puccio, H. M. (2009) · Journal of Neurology · doi:10.1007/s00415-009-1004-1 · Cited by 58
Silencing of frataxin gene expression triggers p53-dependent apoptosis in human neuron-like cells
Palomo, G. M., Cerrato, T., Gargini, R., & Díaz‐Nido, J. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr187 · Cited by 56
Coppola, G., Choi, S.-H., Santos, M. M., Miranda, C. J., Tentler, D., Wexler, E., Pandolfo, M., & Geschwind, D. H. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.11.014 · Cited by 58
Biogenesis of iron–sulfur proteins in eukaryotes: components, mechanism and pathology
Gerber, J., & Lill, R. (2002) · Mitochondrion · doi:10.1016/s1567-7249(02)00041-7 · Cited by 54
Future Prospects of Gene Therapy for Friedreich’s Ataxia
Ocana-Santero, G., Díaz‐Nido, J., & Herranz-Martín, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041815 · Cited by 53
Nachun, D. C., Gao, F., Isaacs, C. J., Strawser, C. J., Yang, Z., Dokuru, D. R., Berlo, V. V., Sears, R., Farmer, J. M., Perlman, S., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy198 · Cited by 53
Drosophila Glia: Models for Human Neurodevelopmental and Neurodegenerative Disorders
Kim, T., Song, B., & Lee, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144859 · Cited by 57
The Molecular Basis of Friedreich Ataxia
Pandolfo, M. (2002) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0117-6_5 · Cited by 52
Soriano, S., Llorens, J. V., Blanco-Sobero, L., Gutiérrez, L., Calap-Quintana, P., Morales, M. P., Moltó, M. D., & Martínez-Sebastián, M. J. (2013) · Gene · doi:10.1016/j.gene.2013.02.049 · Cited by 51
Eigentler, A., Boesch, S., Schneider, R., Dechant, G., & Nat, R. (2013) · Stem Cells and Development · doi:10.1089/scd.2013.0126 · Cited by 50
Histone Deacetylase Inhibitors: A Therapeutic Key in Neurological Disorders?
Ziemka‐Nałęcz, M., Jaworska, J., Sypecka, J., & Zalewska, T. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly073 · Cited by 53
Molecular basis of Friedreich ataxia
Pandolfo, M. (2001) · Movement Disorders · doi:10.1002/mds.1162 · Cited by 48
Human BAC-mediated rescue of the Friedreich ataxia knockout mutation in transgenic mice
Sarsero, J. P., Li, L., Holloway, T. P., Voullaire, L. E., Gazeas, S., Fowler, K. J., Kirby, D. M., Thorburn, D. R., Galle, A., Cheema, S. S., et al. (2004) · Mammalian Genome · doi:10.1007/s00335-004-3019-3 · Cited by 48
Chromosome instability and tumor predisposition inversely correlate with BLM protein levels
McDaniel, L. D., Chester, N., Watson, M. L., Borowsky, A. D., Leder, P., & Schultz, R. A. (2003) · DNA repair · doi:10.1016/j.dnarep.2003.08.006 · Cited by 46
Animal models for respiratory chain disease
Larsson, N., & Rustin, P. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02167-0 · Cited by 48
Generation of Artificial Gamete and Embryo From Stem Cells in Reproductive Medicine
Zhang, P.-Y., Fan, Y., Tan, T., & Yu, Y. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00781 · Cited by 47
Molecular insights into Friedreich's ataxia and antioxidant-based therapies
Rötig, A., Sidi, D., Munnich, A., & Rustin, P. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02330-4 · Cited by 46
Busi, M. V., & Gomez‐Casati, D. F. (2011) · IUBMB Life · doi:10.1002/iub.577 · Cited by 46
Rosa, P. L., Russo, M., D’Amico, J., Petrillo, S., Aquilano, K., Lettieri‐Barbato, D., Turchi, R., Bertini, E., & Piemonte, F. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00356 · Cited by 46
Nordin, A., Larsson, E., Thornell, L., & Holmberg, M. (2010) · Human Genetics · doi:10.1007/s00439-010-0931-3 · Cited by 45
Friedreich Ataxia: Detection of GAA Repeat Expansions and Frataxin Point Mutations
Pandolfo, M. (2006) · Humana Press eBooks · doi:10.1385/1-59745-088-x:197 · Cited by 44
Loría, F., & Díaz‐Nido, J. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.12.017 · Cited by 41
Monfort, B., Want, K., Gervason, S., & D’Autréaux, B. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.838335 · Cited by 42
Epidemiology of inherited cerebellar ataxias and challenges in clinical research
Pilotto, F., & Saxena, S. (2018) · Clinical and Translational Neuroscience · doi:10.1177/2514183x18785258 · Cited by 44
Induced pluripotent stem cell technology for modelling and therapy of cerebellar ataxia
Watson, L. M., Wong, M. M. K., & Becker, E. B. E. (2015) · Open Biology · doi:10.1098/rsob.150056 · Cited by 41
Molecular chaperones involved in mitochondrial iron–sulfur protein biogenesis
Dutkiewicz, R., & Nowak, M. (2017) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-017-1504-x · Cited by 41
Developmental and neurodegenerative damage in Friedreich's ataxia
de Rezende, T. J. R., Martínez, A., Faber, I., Takazaki, K. A. G., Martins, M. P., de Lima, F. D., Lopes‐Cendes, Í., Cendes, F., & França, M. C. (2018) · European Journal of Neurology · doi:10.1111/ene.13843 · Cited by 41
Manto, M. U., & Marmolino, D. (2009) · The Cerebellum · doi:10.1007/s12311-009-0127-3 · Cited by 40
Fleming, J., Spinoulas, A., Zheng, M., Cunningham, S. C., Ginn, S. L., McQuilty, R. C., Rowe, P. B., & Alexander, I. E. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.947 · Cited by 42
Frataxin deficiency and mitochondrial dysfunction
Pandolfo, M. (2002) · Mitochondrion · doi:10.1016/s1567-7249(02)00039-9 · Cited by 39
Thierbach, R., Drewes, G., Fußer, M., Voigt, A., Kuhlow, D., Blume, U., Schulz, T. J., Reiche, C., Glatt, H. R., Epe, B., et al. (2010) · Biochemical Journal · doi:10.1042/bj20101116 · Cited by 38
Is Friedreich ataxia an epigenetic disorder?
Kumari, D., & Usdin, K. (2012) · Clinical Epigenetics · doi:10.1186/1868-7083-4-2 · Cited by 43
Gordon, D. M. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.3.259 · Cited by 38
Unanswered Questions in Friedreich Ataxia
Lynch, D. R., Deutsch, E. C., Wilson, R. B., & Tennekoon, G. I. (2012) · Journal of Child Neurology · doi:10.1177/0883073812453498 · Cited by 39
Silva, A. M., Brown, J. M., Buckle, V. J., Wade‐Martins, R., & Lufino, M. M. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv096 · Cited by 39
Mitra, J., Guerrero, E. N., Hegde, P. M., Wang, H., Boldogh, I. R., Rao, K. S. J., MITRA, S. P., & Hegde, M. L. (2014) · Biomolecules · doi:10.3390/biom4030678 · Cited by 37
Brehm, M. A., Powers, A. C., Shultz, L. D., & Greiner, D. L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007757 · Cited by 37
Nordin, A., Larsson, E., & Holmberg, M. (2011) · Human Mutation · doi:10.1002/humu.22002 · Cited by 36
Mitochondrial biology and dysfunction in secondary mitochondrial disease
Baker, M. J., Crameri, J. J., Thorburn, D. R., Frazier, A. E., & Stojanovski, D. (2022) · Open Biology · doi:10.1098/rsob.220274 · Cited by 39
Methylene blue rescues heart defects in a Drosophila model of Friedreich's ataxia
Tricoire, H., Palandri, A., Bourdais, A., Camadro, J., & Monnier, V. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt493 · Cited by 41
Increased IRP1 activity in Friedreich ataxia
Lobmayr, L., Brooks, D. G., & Wilson, R. B. (2005) · Gene · doi:10.1016/j.gene.2005.04.040 · Cited by 35
Therapeutic Developments in Friedreich Ataxia
Wilson, R. B. (2012) · Journal of Child Neurology · doi:10.1177/0883073812449691 · Cited by 36
The heart in Friedreich's Ataxia: Basic findings and clinical implications
Payne, R. M. (2011) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2011.02.007 · Cited by 36
Vannocci, T., Manzano, R. N., Beccalli, O., Bettegazzi, B., Grohovaz, F., Cinque, G., Riso, A. D., Quaroni, L. G., Codazzi, F., & Pastore, A. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.032706 · Cited by 35
Torraco, A., Stehling, O., Stümpfig, C., Rösser, R., Rasmo, D. D., Fiermonte, G., Verrigni, D., Rizza, T., Vozza, A., Nottia, M. D., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy183 · Cited by 33
Mitochondrial metals as a potential therapeutic target in neurodegeneration
Grubman, A., White, A. R., & Liddell, J. R. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12513 · Cited by 33
Modeling human mitochondrial diseases in flies
Sánchez-Martínez, Á., Luo, N., Clemente, P., Adán, C., Hernández‐Sierra, R., Amo‐Ochoa, P., Fernández‐Moreno, M. Á., Kaguni, L. S., & Garesse, R. (2006) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2006.05.008 · Cited by 37
Frataxin and frataxin deficiency in Friedreich's ataxia
Wilson, R. B. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00432-x · Cited by 32
Doni, D., Cavion, F., Bortolus, M., Baschiera, E., Muccioli, S., Tombesi, G., d’Ettorre, F., Ottaviani, D., Marchesan, E., Leanza, L., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06320-y · Cited by 32
Lin, H., Magrané, J., Clark, E. M., Halawani, S. M., Warren, N., Rattelle, A., & Lynch, D. R. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.030049 · Cited by 32
Collins, A. R. (2013) · Neurologic Clinics · doi:10.1016/j.ncl.2013.05.002 · Cited by 31
Hannan, A. J. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5434-2_1 · Cited by 34
Miranda, C. J., Santos, M. M., Ohshima, K., Tessaro, M., Sequeiros, J., & Pandolfo, M. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.07.022 · Cited by 30
Pathophysiogical and therapeutic progress in Friedreich ataxia
Puccio, H. M., Anheim, M., & Tranchant, C. (2014) · Revue Neurologique · doi:10.1016/j.neurol.2014.03.008 · Cited by 31
Pharmacotherapy for Friedreich Ataxia
Tsou, A. Y., Friedman, L. S., Wilson, R. B., & Lynch, D. R. (2009) · CNS Drugs · doi:10.2165/00023210-200923030-00003 · Cited by 30
Friedreich ataxia: metal dysmetabolism in dorsal root ganglia
Koeppen, A. H., Kuntzsch, E. C., Bjork, S. T., Ramirez, R. L., Mazurkiewicz, J. E., & Feustel, P. J. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-26 · Cited by 30
Bird, M., Needham, K., Frazier, A. E., van Rooijen, J., Leung, J., Hough, S. R., Denham, M., Thornton, M. E., Parish, C. L., Nayagam, B. A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101718 · Cited by 31
Koeppen, A. H., Ramirez, R. L., Becker, A. B., Feustel, P. J., & Mazurkiewicz, J. E. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000160 · Cited by 30
Bousquet, P. A., Sandvik, J. A., Edin, N. F. J., & Krengel, U. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.11.183 · Cited by 31
Clinical and genetic aspects of defects in the mitochondrial iron–sulfur cluster synthesis pathway
Vanlander, A. V., & Coster, R. V. (2018) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-018-1550-z · Cited by 29
The expanding spectrum of nuclear gene mutations in mitochondrial disorders
Zeviani, M. (2001) · Seminars in Cell and Developmental Biology · doi:10.1006/scdb.2001.0278 · Cited by 28
Franco, C., Fernández, S., & Torres‐Alemán, I. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-51 · Cited by 28
Neurobehavioral deficits in the KIKO mouse model of Friedreich’s ataxia
McMackin, M. Z., Henderson, C. K., & Cortopassi, G. A. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.08.053 · Cited by 28
Friedreich's ataxia: treatment within reach
Dürr, A. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00162-x · Cited by 28
Metadata
- Authors
- Cossee, M.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-05-01
- Volume
- 9
- Issue
- 8
- Pages
- 1219-1226
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2114190171
- Cited by
- 377
- References
- 23
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 11 · 2023: 9 · 2022: 8 · 2021: 11 · 2020: 10 · 2019: 11 · 2018: 16 · 2017: 16 · 2016: 6 · 2015: 11 · 2014: 20 · 2013: 25 · 2012: 19
- FWCI
- 8.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Muscular Dystrophy Association
- Institut National de la Santé et de la Recherche Médicale
- Centre National de la Recherche Scientifique
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- Friedreich's ataxia, frataxin, embryonic lethality, iron-sulfur proteins, mitochondrial iron homeostasis, iron accumulation, mouse model, cell death mechanisms
- MeSH terms
- Frataxin, Animals, Decidua, Embryo, Mammalian, Exons, Female, Fetal Death, Friedreich Ataxia, Genotype, Homozygote, Humans, Introns, Iron, Iron-Sulfur Proteins, Necrosis, Phenotype, Pregnancy, Apoptosis, Phosphotransferases (Alcohol Group Acceptor), Mice, Knockout, Iron-Binding Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review